Drug intelligence / Profile preview

multi-oil fat emulsion injection (C6~24)

Development stage
Phase 3
Lead developer
Chengdu Guowei Biopharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Multi-oil fat emulsion injection (C6~24) is a multi-component intravenous lipid emulsion used for parenteral nutrition. It provides energy, essential fatty acids, and omega-3 fatty acids to patients who cannot obtain adequate nutrition via oral or enteral routes. The emulsion is composed of a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil, spanning a carbon chain range of C6 to C24. It is being co-developed in China by Chengdu Guowei Biopharmaceutical and Sichuan Kelun Pharmaceutical (with Kelun acting as the contract manufacturer) as a generic version of the reference product SMOFlipid (marketed as Hewen by Fresenius Kabi). The drug is indicated for postoperative nutritional deficiency and malnutrition, particularly as parenteral nutrition support for patients undergoing elective abdominal surgery who require 100% of daily energy intake from parenteral nutrition.

Brand names
HewenSMOFlipid合文
Other names
multi-oil fat emulsion (C6-24)multi-oil fat emulsion injection (C6-24)多种油脂肪乳(C6-24)多种油脂肪乳注射液(C6-24)多种油脂肪乳注射液(C6~24)多种油脂肪乳注射液(C6~24)
02

Targets

COX15-LOX (Lysyl Oxidase)PPAR (PPAR family)PLA2 (Phospholipase A2 group IID)

Beyond the preview

Go deeper on multi-oil fat emulsion injection (C6~24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multi-oil fat emulsion injection (C6~24).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call